First Western Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-37,548
Closed -$2.69M 58
2017
Q4
$2.69M Buy
37,548
+949
+3% +$72.1K 1.53% 34
2017
Q3
$2.96M Buy
36,599
+710
+2% +$54.3K 1.8% 29
2017
Q2
$2.54M Buy
35,889
+456
+1% +$30.3K 1.53% 31
2017
Q1
$2.41M Sell
35,433
-1,413
-4% -$99.4K 1.46% 31
2016
Q4
$2.64M Sell
36,846
-596
-2% -$44.3K 1.43% 30
2016
Q3
$2.96M Sell
37,442
-2,039
-5% -$166K 1.15% 35
2016
Q2
$3.29M Sell
39,481
-25,234
-39% -$2.24M 1.2% 34
2016
Q1
$5.95M Sell
64,715
-7,029
-10% -$634K 2.11% 8
2015
Q4
$7.26M Buy
71,744
+2,867
+4% +$298K 2.27% 8
2015
Q3
$6.76M Buy
68,877
+3,983
+6% +$442K 2.26% 5
2015
Q2
$7.6M Buy
64,894
+1,686
+3% +$184K 2.44% 3
2015
Q1
$6.2M Sell
63,208
-13,113
-17% -$1.33M 1.86% 10
2014
Q4
$7.19M Sell
76,321
-2,556
-3% -$264K 2.12% 8
2014
Q3
$8.4M Buy
78,877
+14,536
+23% +$1.42M 2.48% 2
2014
Q2
$5.33M Sell
64,341
-96
-0.1% -$7.47K 1.76% 10
2014
Q1
$4.57M Sell
64,437
-2,973
-4% -$233K 1.61% 13
2013
Q4
$5.06M Buy
+67,410
New +$4.69M 1.75% 9

Other funds holding GILD

First Western Capital Management's GILD Position: Q1 2018 in Review

First Western Capital Management sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 37,548 shares — an estimated $2.69M sold.

First Western Capital Management first reported a position in GILD in Q4 2013 and held it in 17 quarters. The position peaked at $8.4M in Q3 2014. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • First Western Capital Management reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • First Western Capital Management sold 37,548 Gilead Sciences shares in Q1 2018, an estimated $2.69M.
  • First Western Capital Management first reported a position in Gilead Sciences in Q4 2013 and held it in 17 quarters.
  • First Western Capital Management's Gilead Sciences position peaked at $8.4M in Q3 2014.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on First Western Capital Management's 13F filing for Q1 2018, filed 14 May 2018.